Log in | Register

Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?

Gaël Piton| Cyril Manzon| Benoit Cypriani| Franck Carbonnel| Gilles Capellier
Review
Volume 37, Issue 6 / June , 2011

Pages 911 - 917

Abstract

Introduction

Small bowel functions are more complex than colon functions, and short bowel conditions are associated with increased mortality. Gastrointestinal dysfunction in critically ill patients is common, probably underestimated, and associated with a poor prognosis. However, a validated definition of acute intestinal failure is lacking, in absence of a marker to measure it. Consequently, small bowel dysfunction is not clearly integrated into the overall approach used to treat ICU patients.

Materials and Methods

Review of the literature on gastrointestinal dysfunction in critically ill patients, and proposition of a definition of acute intestinal failure.

Conclusion

On the one hand, small bowel ischemia is related to acute reduction of enterocyte mass and loss of gut barrier function by epithelial lifting of villi. On the other hand, systemic inflammatory response syndrome (SIRS) and sepsis could be linked to an acute dysfunction of enterocytes without enterocyte reduction. Citrulline is an amino acid mainly synthesized by small bowel enterocytes. Various contexts of chronic and acute reduction of enterocyte mass have been correlated with low plasma citrulline concentration. Critically ill patients with shock have an acute reduction of enterocyte mass and reduced gut citrulline synthesis, leading to a low plasma citrulline concentration. Acute intestinal failure could be defined as an acute reduction of enterocyte mass and/or acute dysfunction of enterocytes, associated or not with loss of gut barrier function. The influence of SIRS and acute renal failure on plasma citrulline concentration and the value of this concentration as an indicator of acute intestinal failure in critically ill patients must be further evaluated.

Keywords

References

  1. Abu-Elmagd KM (2006) Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 130:S132–S137
    • View reference on PubMed
    • View reference on publisher's website
  2. Lloyd DA, Vega R, Bassett P, Forbes A, Gabe SM (2006) Survival and dependence on home parenteral nutrition: experience over a 25 year period in a UK referral centre. Aliment Pharmacol Ther 24:1231–1240
    • View reference on PubMed
    • View reference on publisher's website
  3. Messing B, Joly F (2006) Guidelines for management of home parenteral support in adult chronic intestinal failure patients. Gastroenterology 130:S43–S51
    • View reference on PubMed
    • View reference on publisher's website
  4. Jones BA, Gores GJ (1997) Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol 273:G1174–G1188
    • View reference on PubMed
  5. Mayhew TM, Myklebust R, Whybrow A, Jenkins R (1999) Epithelial integrity, cell death and cell loss in mammalian small intestine. Histol Histopathol 14:257–267
    • View reference on PubMed
  6. Reintam A, Parm P, Kitus R, Kern H, Starkopf J (2009) Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand 53:318–324
    • View reference on PubMed
    • View reference on publisher's website
  7. Gaussorgues P, Gueugniaud PY, Vedrinne JM, Salord F, Mercatello A, Robert D (1988) Bacteremia following cardiac arrest and cardiopulmonary resuscitation. Intensive Care Med 14:575–577
  8. Deitch EA (1992) Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216:117–134
    • View reference on PubMed
    • View reference on publisher's website
  9. Fiddian-Green RG (1988) Splanchnic ischaemia and multiple organ failure in the critically ill. Ann R Coll Surg Engl 70:128–134
    • View reference on PubMed
  10. Hallback DA, Hulten L, Jodal M, Lindhagen J, Lundgren O (1978) Evidence for the existence of a countercurrent exchanger in the small intestine in man. Gastroenterology 74:683–690
    • View reference on PubMed
  11. Lundgren O (1974) The circulation of the small bowel mucosa. Gut 15:1005–1013
    • View reference on PubMed
    • View reference on publisher's website
  12. Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, Wen LQ, Wu W, Jiang ZP, Huang ZT (2005) Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World J Gastroenterol 11:5485–5491
    • View reference on PubMed
  13. Leung FW, Su KC, Passaro E Jr, Guth PH (1992) Regional differences in gut blood flow and mucosal damage in response to ischemia and reperfusion. Am J Physiol 263:G301–G305
    • View reference on PubMed
  14. Ahren C, Haglund U (1973) Mucosal lesions in the small intestine of the cat during low flow. Acta Physiol Scand 88:541–550
    • View reference on PubMed
    • View reference on publisher's website
  15. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN (1970) Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101:478–483
    • View reference on PubMed
  16. Haglund U, Hulten L, Ahren C, Lundgren O (1975) Mucosal lesions in the human small intestine in shock. Gut 16:979–984
    • View reference on PubMed
    • View reference on publisher's website
  17. Derikx JP, Matthijsen RA, de Bruine AP, van Dam RM, Buurman WA, Dejong CH (2009) A new model to study intestinal ischemia-reperfusion damage in Man. J Surg Res. doi:10.1016/j.jss.2009.09.046
  18. Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatakeyama K (1996) Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110:339–343
    • View reference on PubMed
    • View reference on publisher's website
  19. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ (2003) Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 7:26–35 discussion 35–26
    • View reference on PubMed
    • View reference on publisher's website
  20. Besselink MG, van Santvoort HC, Renooij W, de Smet MB, Boermeester MA, Fischer K, Timmerman HM, Ahmed Ali U, Cirkel GA, Bollen TL, van Ramshorst B, Schaapherder AF, Witteman BJ, Ploeg RJ, van Goor H, van Laarhoven CJ, Tan AC, Brink MA, van der Harst E, Wahab PJ, van Eijck CH, Dejong CH, van Erpecum KJ, Akkermans LM, Gooszen HG (2009) Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg 250:712–719
    • View reference on PubMed
    • View reference on publisher's website
  21. van Haren FM, Pickkers P, Foudraine N, Heemskerk S, Sleigh J, van der Hoeven JG (2010) The effects of methylene blue infusion on gastric tonometry and intestinal fatty acid binding protein levels in septic shock patients. J Crit Care 25(358):e351–e357
  22. Derikx JP, Matthijsen RA, de Bruine AP, van Bijnen AA, Heineman E, van Dam RM, Dejong CH, Buurman WA (2008) Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One 3:e3428
    • View reference on PubMed
    • View reference on publisher's website
  23. Fleming C (1981) Remington M Nutrition and the surgical patient. In: Hill GL (ed) Intestinal failure. Churchill Livingstone, New York, pp 219–235
  24. Nightingale J (2001) Introduction: definition and classification of intestinal failure. In: Nightingale JMD (ed) Intestinal failure. GMM, London, p XIX
  25. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. Jama 270:2957–2963
    • View reference on PubMed
    • View reference on publisher's website
  26. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
  27. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C (1993) Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 19:137–144
  28. Malbrain ML, De Laet I (2008) AIDS is coming to your ICU: be prepared for acute bowel injury and acute intestinal distress syndrome. Intensive Care Med 34:1565–1569
  29. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppaniemi A, Olvera C, Ivatury R, D’Amours S, Wendon J, Hillman K, Johansson K, Kolkman K, Wilmer A (2006) Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. definitions. Intensive Care Med 32:1722–1732
  30. Reintam A, Parm P, Kitus R, Starkopf J, Kern H (2008) Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care 12:R90
    • View reference on PubMed
    • View reference on publisher's website
  31. Khadaroo RG, Marshall JC (2008) Gastrointestinal dysfunction in the critically ill: can we measure it? Crit Care 12:180
    • View reference on PubMed
    • View reference on publisher's website
  32. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, Cynober L (2005) Almost all about citrulline in mammals. Amino Acids 29:177–205
    • View reference on PubMed
    • View reference on publisher's website
  33. Crenn P, Messing B, Cynober L (2008) Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 27:328–339
    • View reference on PubMed
    • View reference on publisher's website
  34. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B (2000) Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 119:1496–1505
    • View reference on PubMed
    • View reference on publisher's website
  35. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B (2003) Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 124:1210–1219
    • View reference on PubMed
    • View reference on publisher's website
  36. Papadia C, Sherwood RA, Kalantzis C, Wallis K, Volta U, Fiorini E, Forbes A (2007) Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 102:1474–1482
    • View reference on PubMed
    • View reference on publisher's website
  37. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C (1980) Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 65:1162–1173
    • View reference on PubMed
    • View reference on publisher's website
  38. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB (2002) Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 36:1163–1171
    • View reference on PubMed
    • View reference on publisher's website
  39. Herbers AH, Feuth T, Donnelly JP, Blijlevens NM (2010) Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol 21:1706–1711
    • View reference on PubMed
    • View reference on publisher's website
  40. Wedlake L, McGough C, Hackett C, Thomas K, Blake P, Harrington K, Tait D, Khoo V, Dearnaley D, Andreyev HJ (2008) Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa? Aliment Pharmacol Ther 27:980–987
    • View reference on PubMed
    • View reference on publisher's website
  41. Ruiz P, Tryphonopoulos P, Island E, Selvaggi G, Nishida S, Moon J, Berlanga A, Defranc T, Levi D, Tekin A, Tzakis AG (2010) Citrulline evaluation in bowel transplantation. Transplant Proc 42:54–56
    • View reference on PubMed
    • View reference on publisher's website
  42. Herbers AH, Blijlevens NM, Donnelly JP, de Witte TJ (2008) Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. Bone Marrow Transplant 42:345–349
    • View reference on PubMed
    • View reference on publisher's website
  43. van Vliet MJ, Tissing WJ, Rings EH, Koetse HA, Stellaard F, Kamps WA, de Bont ES (2009) Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients. Pediatr Blood Cancer 53:1188–1194
    • View reference on PubMed
    • View reference on publisher's website
  44. Pan L, Wang X, Li W, Li N, Li J (2010) The intestinal fatty acid binding protein diagnosing gut dysfunction in acute pancreatitis: a pilot study. Pancreas 39:633–638
    • View reference on PubMed
    • View reference on publisher's website
  45. Hietbrink F, Besselink MG, Renooij W, de Smet MB, Draisma A, van der Hoeven H, Pickkers P (2009) Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock 32:374–378
    • View reference on PubMed
    • View reference on publisher's website
  46. Piton G, Manzon C, Monnet E, Cypriani B, Barbot O, Navellou JC, Carbonnel F, Capellier G (2010) Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med 36(4):702–706
  47. Hersch M, Scott JA, Izbicki G, McCormack D, Cepinkas G, Ostermann M, Sibbald WJ (2005) Differential inducible nitric oxide synthase activity in circulating neutrophils vs. mononuclears of septic shock patients. Intensive Care Med 31:1132–1135
  48. Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F (2009) Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond) 117:23–30
    • View reference on publisher's website
  49. Luiking YC, Poeze M, Ramsay G, Deutz NE (2009) Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 89:142–152
    • View reference on PubMed
    • View reference on publisher's website
  50. Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L (1997) Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem 43:1421–1428
    • View reference on PubMed
  51. Demacker PN, Beijers AM, van Daal H, Donnelly JP, Blijlevens NM, van den Ouweland JM (2009) Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology. J Chromatogr B Analyt Technol Biomed Life Sci 877:387–392
    • View reference on PubMed
    • View reference on publisher's website
  52. van Waardenburg DA, de Betue CT, Luiking YC, Engel M, Deutz NE (2007) Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am J Clin Nutr 86:1438–1444
    • View reference on PubMed
  53. Freund H, Atamian S, Holroyde J, Fischer JE (1979) Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 190:571–576
    • View reference on PubMed
    • View reference on publisher's website
  54. Luiking YC, Deutz NE (2007) Exogenous arginine in sepsis. Crit Care Med 35:S557–S563
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement